The cyclooxygenase-2 pathway via the PGE₂ EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination.

作者: Sara Palumbo , Christopher D. Toscano , Laura Parente , Roberto Weigert , Francesca Bosetti

DOI: 10.1111/J.1471-4159.2011.07363.X

关键词: MyelinOligodendrocyteInflammationSignal transductionReceptor antagonistCyclooxygenaseReceptorBiologyImmunologyMultiple sclerosisCancer research

摘要: Cyclooxygenases (COX)-1 and -2 are key enzymes required for the conversion of arachidonic acid to eicosanoids, potent mediators inflammation. In patients with multiple sclerosis, COX-2 derived prostaglandins (PGs) elevated in CSF is up-regulated demyelinating plaques. However, it not known whether activity contributes oligodendrocyte death. cuprizone-induced demyelination, apoptosis a concomitant increase gene expression PGE₂-EP2 receptor precede histological demyelination. EP2 were expressed by oligodendrocytes, suggesting causative role COX-2/EP2 pathway initiation death deletion, chronic treatment selective inhibitor celecoxib, or antagonist AH6809 reduced apoptosis, degree demyelination motor dysfunction. These data indicate that PGE₂ open possible new therapeutic approaches sclerosis.

参考文章(44)
Akhlaq A. Farooqui, Lloyd A. Horrocks, Tahira Farooqui, Modulation of inflammation in brain: a matter of fat. Journal of Neurochemistry. ,vol. 101, pp. 577- 599 ,(2006) , 10.1111/J.1471-4159.2006.04371.X
Y. Kihara, T. Matsushita, Y. Kita, S. Uematsu, S. Akira, J.-i. Kira, S. Ishii, T. Shimizu, Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 21807- 21812 ,(2009) , 10.1073/PNAS.0906891106
K. Yoshikawa, S. Palumbo, C.D. Toscano, F. Bosetti, Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage Prostaglandins Leukotrienes and Essential Fatty Acids. ,vol. 85, pp. 43- 52 ,(2011) , 10.1016/J.PLEFA.2011.04.022
Anthony T. Reder, Manjula Thapar, Anna Maria Sapugay, Mark A. Jensen, Eicosenoids Modify Experimental Allergic Encephalomyelitis. American Journal of Therapeutics. ,vol. 2, pp. 711- 720 ,(1995) , 10.1097/00045391-199509000-00020
Chengcan Yao, Daiji Sakata, Yoshiyasu Esaki, Youxian Li, Toshiyuki Matsuoka, Kenji Kuroiwa, Yukihiko Sugimoto, Shuh Narumiya, Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nature Medicine. ,vol. 15, pp. 633- 640 ,(2009) , 10.1038/NM.1968
Jia Ni, Ying-Yi Shu, Yi-Na Zhu, Yun-Feng Fu, Wei Tang, Xiang-Gen Zhong, Hui Wang, Yi-Fu Yang, Jin Ren, Ming-Wei Wang, Jian-Ping Zuo, COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-γ and IL-10 production by inhibiting T-bet expression ☆ Journal of Neuroimmunology. ,vol. 186, pp. 94- 103 ,(2007) , 10.1016/J.JNEUROIM.2007.03.012
Michael H. Barnett, John W. Prineas, Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Annals of Neurology. ,vol. 55, pp. 458- 468 ,(2004) , 10.1002/ANA.20016